The effect of rabbit antithymocyte globulin on human mesenchymal stem cells

Transplant International

Volumn 26, Issue 6, 2013, Pages 651-658

  Franquesa, Marcella ^a,b   Baan, Carla C ^a   Korevaar, Sander S ^a   Engela, Anja U ^a   Roemeling Van Rhijn, Marieke ^a   Weimar, Willem ^a   Betjes, Michiel G H ^a   Grinyo, Josep M ^b   Hoogduijn, Martin J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

antithymocyte globulin; immunomodulation; mesenchymal stem cells; Thymoglobulin; transplantation

Indexed keywords

THYMOCYTE ANTIBODY;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC LYMPHOCYTE; DRUG BINDING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTILYMPHOCYTE SERUM; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; MESENCHYMAL STROMAL CELLS; RABBITS;

EID: 84877999342     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12109     Document Type: Article

References (32)

1. Casiraghi F, Azzollini N, Todeschini M, et al,. Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am J Transplant 2012; 12: 2373.
2. Zheng SX, Weng YL, Zhou CQ, et al,. Comparison of cardiac stem cells and mesenchymal stem cells transplantation on the cardiac electrophysiology in rats with myocardial infarction. Stem Cell Rev 2012 [Epub ahead of print].
3. Bartholomew A, Sturgeon C, Siatskas M, et al,. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42.
4. Popp FC, Renner P, Eggenhofer E, et al,. Mesenchymal stem cells as immunomodulators after liver transplantation. Liver Transpl 2009; 15: 1192.
5. Rackham CL, Chagastelles PC, Nardi NB, Hauge-Evans AC, Jones PM, King AJ,. Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice. Diabetologia 2011; 54: 1127.
6. Perico N, Casiraghi F, Introna M, et al,. Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol 2011; 6: 412.
7. Le Blanc K, Frassoni F, Ball L, et al,. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579.
8. Tan J, Wu W, Xu X, et al,. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 2012; 307: 1169.
9. Hoogduijn MJ, Crop MJ, Korevaar SS, et al,. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin. Transplantation 2008; 86: 1283.
10. Buron F, Perrin H, Malcus C, et al,. Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells. Transplant Proc 2000; 41: 3347.
11. Eggenhofer E, Renner P, Soeder Y, et al,. Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model. Transpl Immunol 2011; 25: 141.
12. Popp FC, Eggenhofer E, Renner P, et al,. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 2008; 20: 55.
13. Regan JF, Lyonnais C, Campbell K, Smith LV, Buelow R,; Group USTM-CS. Total and active thymoglobulin levels: effects of dose and sensitization on serum concentrations. Transpl Immunol 2001; 9: 29.
14. Bonnefoy-Berard N, Verrier B, Vincent C, Revillard JP,. Inhibition of CD25 (IL-2R alpha) expression and T-cell proliferation by polyclonal anti-thymocyte globulins. Immunology 1992; 77: 61.
15. Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N,. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+ CD25+ Foxp3+ 3regulatory T cells. J Am Soc Nephrol 2006; 17: 2844.
16. Hoogduijn MJ, Crop MJ, Peeters AM, et al,. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev 2007; 16: 597.
17. Crop MJ, Baan CC, Korevaar SS, et al,. Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation 2009; 87: 896.
18. van Besouw NM, van der Mast BJ, de Kuiper P, et al,. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 2000; 70: 136.
19. Crop MJ, Baan CC, Korevaar SS, et al,. Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol 2010; 162: 474.
20. Crop MJ, Korevaar SS, de Kuiper R, et al,. Human mesenchymal stem cells are susceptible to lysis by CD8+ T-cells and NK cells. Cell Transplant 2011; 20: 1547.
21. Franquesa M, Herrero E, Torras J, et al,. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev 2012; 21: 3125.
22. Casiraghi F, Azzollini N, Cassis P, et al,. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 2008; 181: 3933.
23. Menard C, Pacelli L, Bassi G, et al,. Clinical-grade mesenchymal stromal cells produced under various GMP processes differ in their immunomodulatory properties: standardization of immune quality controls. Stem Cells Dev 2013 [Epub ahead of print].
24. Gutierrez-Fernandez M, Rodriguez-Frutos B, Ramos-Cejudo J, et al,. Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther 2013; 4: 11.
25. Adutler-Lieber S, Ben-Mordechai T, Naftali-Shani N, et al,. Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells. J Cardiovasc Pharmacol Ther 2013; 18: 78.
26. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J,. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 2012; 21: 2724.
27. Seidel MG, Fritsch G, Matthes-Martin S, et al,. Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2005; 27: 532.
28. Feng X, Kajigaya S, Solomou EE, et al,. Rabbit ATG but not horse ATG promotes expansion of functional CD4+ CD25highFOXP3+ regulatory T cells in vitro. Blood 2008; 111: 3675.
29. Sewgobind VD, van der Laan LJ, Kho MM, et al,. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease. Transplantation 2010; 89: 655.
30. Engela AU, Baan CC, Peeters AM, Weimar W, Hoogduijn MJ,. Interaction between adipose-tissue derived mesenchymal stem cells and regulatory T cells. Cell Transplant 2012; 22: 41.
31. Gurkan S, Luan Y, Dhillon N, et al,. Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant 2010; 10: 2132.
32. Bonanno G, Iudicone P, Mariotti A, et al,. Thymoglobulin, interferon-gamma and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures. J Transl Med 2010; 8: 129.